Tempest Therapeutics, Inc. TPST
0.83
(0.02)
(2.35%)
as of 25 Sep
- Market cap
- $14.4M
- P/E
- 0.0×
Follow TPST
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
2.13 | 2.33 | 0.55 | 0.18 | |
Current Ratio |
2.30 | 2.50 | 0.74 | 0.38 | |
Net Debt/EBITDA |
2.13 | 1.92 | 0.07 | 0.15 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.93 | 0.89 | 0.27 | 0.53 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.53) | (0.86) | (0.69) | (0.18) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(1.53) | (0.86) | (0.69) | (0.18) | |
Cash per Share |
1.69 | 1.86 | 0.17 | 0.05 | |
Shareholders Equity per Share |
1.43 | 1.61 | 0.08 | (0.07) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.43 | 1.61 | 0.08 | (0.07) | |
Free Cash Flow |
(6.78) | (3.57) | (7.60) | (2.78) | |
Working Capital |
4.58 | 4.96 | (0.86) | (2.75) | |
Net Current Asset Value |
(2.68) | (1.99) | (7.48) | (9.03) | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
1.31 | 1.74 | 1.39 | 3.36 | |
Average Assets |
25.48 | 29.21 | 21.46 | 17.06 | |
Average Common Equity |
8.90 | 12.90 | 5.98 | 4.35 |
Columns are period end dates